Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Sullivan, Peter O (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S595000, C514S625000, C514S630000, C548S528000, C564S056000, C564S202000, C564S219000
Reexamination Certificate
active
07981923
ABSTRACT:
Compounds of the formula I, II or III:or pharmaceutically acceptable salts thereof,wherein m, n, q, Ar, R1, R2, R3, R4and R5are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formulas I-III.
REFERENCES:
patent: 5137901 (1992-08-01), Junge et al.
patent: 5374643 (1994-12-01), Atwal et al.
patent: 5412117 (1995-05-01), Koga et al.
patent: 5614633 (1997-03-01), Koga et al.
patent: 5627138 (1997-05-01), Anderson et al.
patent: 5646308 (1997-07-01), Koga et al.
patent: 5663194 (1997-09-01), Mewshaw
patent: 5719182 (1998-02-01), Cousins et al.
patent: 5739135 (1998-04-01), Biller et al.
patent: 5869478 (1999-02-01), Ding et al.
patent: 5874446 (1999-02-01), Koga et al.
patent: 5883099 (1999-03-01), Biller et al.
patent: 5935958 (1999-08-01), Kozlowski et al.
patent: 5977167 (1999-11-01), Koga et al.
patent: 6083982 (2000-07-01), Wechter et al.
patent: 6150402 (2000-11-01), Wechter et al.
patent: 6214881 (2001-04-01), Xiang
patent: 6310107 (2001-10-01), Kato et al.
patent: 6448243 (2002-09-01), Kitazawa et al.
patent: 6479536 (2002-11-01), Ohkawa et al.
patent: 6559144 (2003-05-01), Diefenbach et al.
patent: 6586475 (2003-07-01), Kato et al.
patent: 6605632 (2003-08-01), Lesieur et al.
patent: 6613805 (2003-09-01), Kato et al.
patent: 6638972 (2003-10-01), Kelly et al.
patent: 6660752 (2003-12-01), O'Connor et al.
patent: 6706757 (2004-03-01), Greenblatt et al.
patent: 6784314 (2004-08-01), Yamashita et al.
patent: 7312359 (2007-12-01), Greenhouse et al.
patent: 2002/0002177 (2002-01-01), Cousins et al.
patent: 2004/0024210 (2004-02-01), Johansson et al.
patent: 2004/0077867 (2004-04-01), Kato et al.
patent: 2004/0087577 (2004-05-01), Pratt et al.
patent: 2004/0097492 (2004-05-01), Pratt et al.
patent: 2004/0162285 (2004-08-01), Pratt et al.
patent: 2004/0167123 (2004-08-01), Pratt et al.
patent: 2005/0075331 (2005-04-01), Pratt et al.
patent: 2005/0154053 (2005-07-01), Rhijn et al.
patent: 2006/0167255 (2006-07-01), Greenhouse et al.
patent: 0 488 616 (1992-06-01), None
patent: 0 587 180 (1994-03-01), None
patent: 0 747 374 (1996-12-01), None
patent: WO 97/02259 (1997-01-01), None
patent: WO 98/00412 (1998-01-01), None
patent: WO 01/85172 (2003-05-01), None
patent: WO 03/059356 (2003-07-01), None
patent: WO 03/099801 (2003-12-01), None
patent: WO 04/000828 (2003-12-01), None
patent: WO 2004/058150 (2004-07-01), None
patent: WO 2005/040355 (2005-05-01), None
Dhanak, D., et. al , “Identification and Biological Characterization of Heterocyclic Inhibitors of the Hepatitis C Virus RNA-dependent RNA Polymerase,”J Biological Chem(2002) vol. 277, No. 41, pp. 38322-38327.
Gu, B., et. al , “Arresting Initiation of Hepatitis C Virus RNA Synthesis Using Heterocyclic Derivatives,”J Biological Chem(2003) vol. 278, No. 19, pp. 16602-16607.
Nguyen, T, T., et. al “Resistance Profile of a Hepatitis C Virus RNA-Dependent RNA Polymerase Benzothiadiazine Inhibitor,”Antimicrobial Agents and Chemo(2003) vol. 47, No. 11, pp. 3525-3530.
Harris, III Ralph New
Kress James M.
Repke David Bruce
Stabler Russell Stephen
Hall Robert C.
O Sullivan Peter
Roche Palo Alto LLC
LandOfFree
Tetralin and indane derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetralin and indane derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetralin and indane derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621475